Bliss GVS Pharma Limited has made a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has received an Inspection Closure Report from the World Health Organization (WHO), Geneva, Switzerland, confirming that its manufacturing facility is in compliance with WHO Good Manufacturing Practices (GMP) standards.
The compliant manufacturing facility is located at Survey No. 43 & 44, Vevoor Village, Palghar (East), Dist.- Palghar, 401404, Maharashtra, India. This achievement demonstrates the company's commitment to quality assurance, safety, and operational excellence in its manufacturing processes.
The disclosure was signed by Aditi Bhatt, Company Secretary & Compliance Officer, on June 02, 2026, at 19:26:47 IST. The intimation was submitted to both the National Stock Exchange of India Limited and BSE Limited for information and record purposes.